Latest Breaking News On - Akira takashima - Page 1 : comparemela.com

RepliCel Life Sciences, Inc.: RepliCel Announces Appointment of Leading Dermatologist in Japan as Clinical Advisor VANCOUVER, BC / ACCESSWIRE / May 17, 2021 / RepliCel Life Sciences Inc. (OTCPINK:REPCF) (TSXV:RP) (FRA:P6P2) ( RepliCel or the Company ), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that Professor Akimichi Morita, one of Japan s leading dermatology research clinicians, has agreed to be RepliCel s clinical advisor for the development and commercialization of its skin rejuvenation product (RCS-01) in Japan. The Company, working with industry leaders, CJ Partners, and clinical research organization, Accerise, is currently preparing to support the next-phase clinical research study of its skin rejuvenation cell therapy, RCS-01, in Japan under the Act for Safety of Regenerative Medicine (ASRM) that, upon successfully meeting its endpoints, could lead to a commercial launch of the product in Japan.

United statesBritish columbiaAkimichi moritaPharmacol physiolAkira takashimaLee bucklerReplicel life sciences incAichi cancer centerNagoya city universityHumboldt foundationJournal of dermatological sciencesNagoya city university hospitalJapan ministry of healthUniversity of texas southwestern medical centerJapanese society for the promotion of scienceProfessor jean krutmann at duesseldorf university